You just read:

Artelo Biosciences Enters Into Global R&D Partnership With Syngene International And Aptus Clinical For The Clinical Development Of ART27.13 In Oncology

News provided by

Artelo Biosciences, Inc.

Jun 12, 2018, 08:00 ET